STRS Ohio’s Dianthus Therapeutics DNTH Stock Holding History

STRS Ohio’s Portfolio DNTH Stock Details DNTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-75	Closed	-$3K	–	2102
2022 Q1	$3K	Hold	75	–	–	﹤0.01%	2121
2021 Q4	$5K	Hold	75	–	–	﹤0.01%	2164
2021 Q3	$8K	Hold	75	–	–	﹤0.01%	2208
2021 Q2	$11K	Hold	75	–	–	﹤0.01%	2197
2021 Q1	$14K	Hold	75	–	–	﹤0.01%	2117
2020 Q4	$9K	Hold	75	–	–	﹤0.01%	2110
2020 Q3	$8K	Hold	75	–	–	﹤0.01%	2139
2020 Q2	$9K	Hold	75	–	–	﹤0.01%	2104
2020 Q1	$7K	Hold	75	–	–	﹤0.01%	1957
2019 Q4	$18K	Hold	75	–	–	﹤0.01%	1982
2019 Q3	$12K	Hold	75	–	–	﹤0.01%	2010
2019 Q2	$17K	Hold	75	–	–	﹤0.01%	2040
2019 Q1	$19K	Hold	75	–	–	﹤0.01%	1970
2018 Q4	$6K	Hold	75	–	–	﹤0.01%	2046
2018 Q3	$14K	Buy	+75	New	+$15.8K	﹤0.01%	2062

Other funds holding DNTH

TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

Janus Henderson Group

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return